Listar por autor "Blay Albors, Pilar"
Mostrando ítems 1-8 de 8
-
Germ-line mutations in epidermal growth factor receptor (EGFR) are rare but may contribute to oncogenesis: A novel germ-line mutation in EGFR detected in a patient with lung adenocarcinoma
Centeno Ramos, Irene; Blay Albors, Pilar; Santamaría Ruiz de Azúa, Íñigo; Astudillo González, María Aurora; Sánchez Pitiot, Ana Gloria; García Osorio, Fernando; González Arriaga, Patricia; Iglesias Llaca, Fernando; Menéndez Rodríguez, María Primitiva; Tardón García, Adonina; Pérez Freije, José María; Balbín Felechosa, Milagros (BioMed Central, 2011) -
Impact of the incorporation of tyrosine kinase inhibitor agents on the treatment of patients with a diagnosis of advanced renal cell carcinoma: study based on experience at the Hospital Universitario Central de Asturias
Muriel López, Carolina; Esteban González, Emilio; Corral Blanco, Norberto Octavio; Jiménez Fonseca, Paula; Luque Cabal, María; Berros Fombella, José Pablo; Fernández Pérez, Yolanda; Blay Albors, Pilar; Fra Rodríguez, Joaquín; Villanueva Palicio, Noemí; Fernández de Sanmamed Gutiérrez, Miguel; Pardo Coto, Pablo; Izquierdo Manuel, Marta; Viéitez de Prado, José María; Estrada Hernández, Enrique; Jiménez Lacave, Ángel (2010)